BRPI1016266A2 - compostos antivirais heterocíclicos - Google Patents
compostos antivirais heterocíclicosInfo
- Publication number
- BRPI1016266A2 BRPI1016266A2 BRPI1016266A BRPI1016266A BRPI1016266A2 BR PI1016266 A2 BRPI1016266 A2 BR PI1016266A2 BR PI1016266 A BRPI1016266 A BR PI1016266A BR PI1016266 A BRPI1016266 A BR PI1016266A BR PI1016266 A2 BRPI1016266 A2 BR PI1016266A2
- Authority
- BR
- Brazil
- Prior art keywords
- antiviral compounds
- heterocyclic antiviral
- heterocyclic
- compounds
- antiviral
- Prior art date
Links
- 230000000840 anti-viral effect Effects 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 125000000623 heterocyclic group Chemical group 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4433—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
- C07D491/048—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US15820709P | 2009-03-06 | 2009-03-06 | |
| PCT/EP2010/052661 WO2010100178A1 (en) | 2009-03-06 | 2010-03-03 | Heterocyclic antiviral compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI1016266A2 true BRPI1016266A2 (pt) | 2019-09-24 |
Family
ID=42102526
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI1016266A BRPI1016266A2 (pt) | 2009-03-06 | 2010-03-03 | compostos antivirais heterocíclicos |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US8168792B2 (pt) |
| EP (1) | EP2403844A1 (pt) |
| JP (1) | JP2012519661A (pt) |
| KR (1) | KR20110122874A (pt) |
| CN (1) | CN102341382A (pt) |
| AR (1) | AR075718A1 (pt) |
| AU (1) | AU2010220374A1 (pt) |
| BR (1) | BRPI1016266A2 (pt) |
| CA (1) | CA2752443A1 (pt) |
| IL (1) | IL214288A0 (pt) |
| MX (1) | MX2011008641A (pt) |
| SG (1) | SG174252A1 (pt) |
| TW (1) | TW201035083A (pt) |
| WO (1) | WO2010100178A1 (pt) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2007345526B2 (en) | 2007-02-01 | 2013-02-28 | Resverlogix Corp. | Compounds for the prevention and treatment of cardiovascular diseases |
| WO2010079431A2 (en) | 2009-01-08 | 2010-07-15 | Resverlogix Corp. | Compounds for the prevention and treatment of cardiovascular disease |
| US10752611B2 (en) | 2009-02-27 | 2020-08-25 | Enanta Pharmaceuticals, Inc. | Benzimidazole derivatives |
| AU2010224523B2 (en) | 2009-03-18 | 2014-05-08 | Resverlogix Corp. | Novel anti-inflammatory agents |
| MX374414B (es) | 2009-04-22 | 2025-03-06 | Resverlogix Corp | Nuevos agentes anti-inflamatorios. |
| US8734777B2 (en) * | 2010-08-13 | 2014-05-27 | Roche Palo Alto Llc | Heterocyclic antiviral compounds |
| LT2773354T (lt) | 2011-11-01 | 2019-08-12 | Resverlogix Corp. | Geriamosios greitai atsipalaiduojančios pakeistų chinozolinų vaisto formos |
| DK2822656T3 (en) | 2012-03-07 | 2017-01-30 | Inst Of Cancer Research: Royal Cancer Hospital (The) | 3-aryl-5-substituted-isoquinolin-1-one compounds and their therapeutic use |
| US9073878B2 (en) | 2012-11-21 | 2015-07-07 | Zenith Epigenetics Corp. | Cyclic amines as bromodomain inhibitors |
| WO2014080291A2 (en) | 2012-11-21 | 2014-05-30 | Rvx Therapeutics Inc. | Biaryl derivatives as bromodomain inhibitors |
| US9271978B2 (en) | 2012-12-21 | 2016-03-01 | Zenith Epigenetics Corp. | Heterocyclic compounds as bromodomain inhibitors |
| WO2015017382A1 (en) * | 2013-07-29 | 2015-02-05 | Enanta Pharmaceuticals, Inc. | Hepatitis c virus inhibitors |
| EP3044221B1 (en) | 2013-09-11 | 2018-02-21 | Institute of Cancer Research: Royal Cancer Hospital (The) | 3-aryl-5-substituted-isoquinolin-1-one compounds and their therapeutic use |
| CN107530356A (zh) | 2015-03-13 | 2018-01-02 | 雷斯韦洛吉克斯公司 | 用于治疗补体相关疾病之组合物及治疗方法 |
| CN106810557B (zh) * | 2015-11-27 | 2021-05-04 | 南京圣和药物研发有限公司 | 杂环化合物及其应用 |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6323180B1 (en) | 1998-08-10 | 2001-11-27 | Boehringer Ingelheim (Canada) Ltd | Hepatitis C inhibitor tri-peptides |
| WO2001047833A1 (en) | 1999-12-24 | 2001-07-05 | Asahi Glass Company, Limited | Silicon nitride filter and method of manufacture thereof |
| EP1292310A1 (en) | 2000-05-10 | 2003-03-19 | SmithKline Beecham Corporation | Novel anti-infectives |
| US6448281B1 (en) | 2000-07-06 | 2002-09-10 | Boehringer Ingelheim (Canada) Ltd. | Viral polymerase inhibitors |
| AR036081A1 (es) | 2001-06-07 | 2004-08-11 | Smithkline Beecham Corp | Compuesto de 1,2-dihidroquinolina, su uso para preparar una composicion farmaceutica, metodos para prepararlo y compuestos del acido 2-aminobenzoico n-alquilado de utilidad como intermediarios en dichos metodos |
| AR035543A1 (es) | 2001-06-26 | 2004-06-16 | Japan Tobacco Inc | Agente terapeutico para la hepatitis c que comprende un compuesto de anillo condensado, compuesto de anillo condensado, composicion farmaceutica que lo comprende, compuestos de benzimidazol, tiazol y bifenilo utiles como intermediarios para producir dichos compuestos, uso del compuesto de anillo con |
| WO2003007945A1 (en) | 2001-07-20 | 2003-01-30 | Boehringer Ingelheim (Canada) Ltd. | Viral polymerase inhibitors |
| US6899700B2 (en) | 2001-08-29 | 2005-05-31 | Kimberly-Clark Worldwide, Inc. | Therapeutic agent delivery tampon |
| AU2002359320A1 (en) | 2001-10-29 | 2003-05-12 | Smithkline Beecham Corporation | Novel anit-infectives |
| WO2003059356A2 (en) | 2001-10-30 | 2003-07-24 | Smithkline Beecham Corporation | Novel anti-infectives |
| AU2003248566A1 (en) | 2002-05-24 | 2003-12-12 | Smithkline Beecham Corporation | Novel anti-infectives |
| ATE493408T1 (de) * | 2002-11-01 | 2011-01-15 | Abbott Lab | Antiinfektiöse mittel |
| US20040097492A1 (en) | 2002-11-01 | 2004-05-20 | Pratt John K | Anti-infective agents |
| BR0315897A (pt) * | 2002-11-01 | 2008-05-13 | Abbott Lab | agentes antiinfecciosos |
| TWI332507B (en) | 2002-11-19 | 2010-11-01 | Hoffmann La Roche | Antiviral nucleoside derivatives |
| WO2004052313A2 (en) | 2002-12-11 | 2004-06-24 | Smithkline Beecham Corporation | Anti-infectives |
| AU2003300956A1 (en) | 2002-12-11 | 2004-06-30 | Smithkline Beecham Corporation | Anti-infectives |
| AU2003297235A1 (en) | 2002-12-17 | 2004-07-22 | Smithkline Beecham Corporation | Anti-infectives |
| WO2005019191A2 (en) | 2003-08-25 | 2005-03-03 | Abbott Laboratories | 1, 1-dioxido-4h-1,2,4-benzothiadiazine derivate und verwandte verbindungen als inhibitoren der hcv polymerase zur behandlung von hepatitis c |
| AU2005276648A1 (en) | 2004-08-23 | 2006-03-02 | F. Hoffmann-La Roche Ag | Heterocyclic antiviral compounds |
| US20070163927A1 (en) | 2006-01-05 | 2007-07-19 | M-I L.L.C. | Vapor extracting and separator cleaning apparatus |
| KR20090094154A (ko) * | 2006-12-22 | 2009-09-03 | 쉐링 코포레이션 | Ｈｃｖ 및 관련 바이러스 감염을 치료 또는 예방하기 위한 4,5-환 환상 인돌 유도체 |
| HRP20110632T1 (hr) | 2007-09-17 | 2011-10-31 | Abbott Laboratories | N-fenil-diokso-hidropirimidini korisni kao inhibitori virusa hepatitisa c (hcv) |
| JP2011528686A (ja) * | 2008-07-23 | 2011-11-24 | エフ．ホフマン−ラ ロシュ アーゲー | ヘテロ環式抗ウイルス性化合物 |
| RU2015144653A (ru) | 2009-03-25 | 2018-12-29 | Эббви Инк. | Противовирусные соединения и их применения |
| CN102448952B (zh) | 2009-03-25 | 2014-10-29 | Abbvie公司 | 抗病毒化合物和其用途 |
| AR077004A1 (es) * | 2009-06-09 | 2011-07-27 | Hoffmann La Roche | Compuestos heterociclicos antivirales |
-
2010
- 2010-03-03 SG SG2011063781A patent/SG174252A1/en unknown
- 2010-03-03 WO PCT/EP2010/052661 patent/WO2010100178A1/en active Application Filing
- 2010-03-03 KR KR1020117023397A patent/KR20110122874A/ko not_active Ceased
- 2010-03-03 BR BRPI1016266A patent/BRPI1016266A2/pt not_active IP Right Cessation
- 2010-03-03 TW TW099106187A patent/TW201035083A/zh unknown
- 2010-03-03 CN CN2010800106504A patent/CN102341382A/zh active Pending
- 2010-03-03 CA CA2752443A patent/CA2752443A1/en not_active Abandoned
- 2010-03-03 AU AU2010220374A patent/AU2010220374A1/en not_active Abandoned
- 2010-03-03 MX MX2011008641A patent/MX2011008641A/es not_active Application Discontinuation
- 2010-03-03 JP JP2011552427A patent/JP2012519661A/ja active Pending
- 2010-03-03 EP EP10706244A patent/EP2403844A1/en not_active Withdrawn
- 2010-03-04 AR ARP100100641A patent/AR075718A1/es unknown
- 2010-03-05 US US12/718,207 patent/US8168792B2/en not_active Expired - Fee Related
-
2011
- 2011-07-26 IL IL214288A patent/IL214288A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US8168792B2 (en) | 2012-05-01 |
| CA2752443A1 (en) | 2010-09-10 |
| EP2403844A1 (en) | 2012-01-11 |
| US20100226879A1 (en) | 2010-09-09 |
| JP2012519661A (ja) | 2012-08-30 |
| CN102341382A (zh) | 2012-02-01 |
| WO2010100178A1 (en) | 2010-09-10 |
| AR075718A1 (es) | 2011-04-20 |
| AU2010220374A1 (en) | 2011-09-01 |
| KR20110122874A (ko) | 2011-11-11 |
| IL214288A0 (en) | 2011-09-27 |
| MX2011008641A (es) | 2011-09-06 |
| SG174252A1 (en) | 2011-10-28 |
| TW201035083A (en) | 2010-10-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SMT201600351B (it) | Composti antivirali | |
| BR112012005616A2 (pt) | compostos antivirais heterocíclicos | |
| BRPI1010852A2 (pt) | compostos antivirais heterocíclicos | |
| BRPI0916233A2 (pt) | compostos heterocíclicos antivirais | |
| SMT201600008B (it) | Composti di piridazinone | |
| BRPI1016266A2 (pt) | compostos antivirais heterocíclicos | |
| ATE539070T1 (de) | Heterozyklische antivirale verbindungen | |
| DK2427449T3 (da) | Vinylindazolylforbindelser | |
| BR112012006859A2 (pt) | compostos | |
| ECSP12011999A (es) | Derivados benzamida sustituidos | |
| BRPI1013246A2 (pt) | derivados de benzofuralina | |
| BRPI1013614A2 (pt) | compostos substituídos de espiro-amida | |
| BR112012002828A2 (pt) | derivados de 5-fluorpirimidinona | |
| BRPI0924121A2 (pt) | compostos antivirais heterocíclicos | |
| DK2540728T3 (da) | Heterocyklisk forbindelse | |
| BRPI1005525A2 (pt) | compostos de azaazuleno | |
| DK2397480T3 (da) | Diazepindionderivat | |
| BRPI0821349A2 (pt) | compostos antivirais heterocíclicos | |
| BRPI0906705A2 (pt) | Composto heterocíclicos | |
| BRPI1013844A2 (pt) | derivados de piridina-isoxazol | |
| BRPI1013493A2 (pt) | composto de pirimidina | |
| BRPI1014454A2 (pt) | derivados de isoxazol-pirazol | |
| DK2387580T3 (da) | Deoxyactagardinderivater | |
| HRP20150932T1 (xx) | Heterocikliäśki spojevi | |
| BR112013010643A2 (pt) | compostos heterocíclicos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] | ||
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2543 DE 01-10-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |